- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
BioForce Nanosciences, Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings, Inc.
(OTC Bulletin Board: BFNH), continues their effort to fund development of
the ViriChip(TM) platform, a patented system designed to rapidly and
nondestructively detect and identify whole viruses. Developed by BioForce
and made possible by BioForce's Nano eNabler(TM) molecular printer, the
ViriChip platform can have a major impact in biodefense by creating
ultraminiaturized biodetection devices.
BioForce Nanosciences has three major product focus areas: 1)
instrumentation, 2) consumables, and 3) applications. The ViriChip platform
is just one application that BioForce's R&D department has developed using
the Nano eNabler system. The ViriChip technology is sensitive and specific
enough to detect a variety of different pathogens based on the availability
of capture reagents. These could include environmental pathogens
(Noroviruses, coxsackieviruses, etc.), pathogens relevant to biodefense
(smallpox, hemorrhagic fever viruses), animal and plant viruses (foot and
mouth disease, rinderpest, Avian influenza, West Nile), and human disease
agents (Human papillomavirus, herpes viruses, SARS).
BioForce Nanosciences is working to gain government and other support
for the ViriChip platform to assist with biodefense, food safety, and
pandemic diseases. "We want to create opportunities to inform scientific
leaders and decision makers about the importance of nanotechnology in the
life sciences," says Dr. Eric Henderson, BioForce's founder and chief
executive officer. "We believe that the technology embodied in our recently
released Nano eNabler(TM) system has the potential to impact nanotechnology
in the life sciences in a profound way."
About BioForce Nanosciences, Inc.
BioForce Nanosciences, Inc. is a wholly owned subsidiary of BioForce
Nanosciences Holdings, Inc. (OTC Bulletin Board: BFNH). BioForce
Nanosciences is a unique company entering into commercialization with over
a decade of research and accomplishment in the field of bionanotechnology.
BioForce has demonstrated the ability to take a product from concept to
commercial sale. For more information, visit http://www.bioforcenano.com .
This news release contains forward-looking information that may be
affected by certain risks and uncertainties, including those risks and
uncertainties described in the Company's most recent filings with the
Securities and Exchange Commission. The Company's actual results could
differ materially from such forward-looking statements. We assume no duty
to update these statements at any future date.
For more information, please click here
BioForce Nanosciences, Inc.
1615 Golden Aspen Drive, Suite 101
Ames, IA 50010 USA
Phone: 515.233.8333 ext. 101
Copyright © PR Newswire Association LLC.If you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Industrial Nanotech, Inc. Provides Shareholder Update August 22nd, 2016
Leading Advanced Materials Manufacturer Pixelligent Closes $10.4 Million in Funding: Capital Will Boost Capacity for North American Manufacturing, Drive Asian Expansion, and Continue Innovation in Solid State Lighting and OLED Display Applications August 16th, 2016
Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016 August 16th, 2016
50 years after the release of the film 'Fantastic Voyage,' science upstages fiction: Science upstages fiction with nanorobotic agents designed to travel in the human body to treat cancer August 25th, 2016
Graphene under pressure August 26th, 2016
Down to the wire: ONR researchers and new bacteria August 18th, 2016
Hexagonal boron nitride semiconductors enable cost-effective detection of neutron signals: Texas Tech University researchers demonstrate hexagonal boron nitride semiconductors as a cost-effective alternative for inspecting overseas cargo containers entering US ports August 17th, 2016
'Second skin' protects soldiers from biological and chemical agents August 5th, 2016
Nanoparticles that speed blood clotting may someday save lives August 23rd, 2016
Curbing the life-long effects of traumatic brain injury August 19th, 2016